Core Scientific Aktie

Core Scientific has closed committed, senior secured credit facilities totaling $600 million, consisting of a $100 million revolving credit line and a $500 million letter of credit facility. Approximately $300 million of restricted cash is expected to be released; CFO Jim Nygaard cites anticipated improvements in capital efficiency and financial flexibility. The loans are guaranteed by domestic subsidiaries and secured by a first-priority lien on substantially all assets; Morgan Stanley, JPMorgan, Goldman Sachs and TD Securities are acting as arrangers. » More on de.investing.com

Shares of Core Scientific trade at $25.30, marking a record high after a 129% rise over the past year and a 70% gain year-to-date. The stock shows high volatility (beta 5.45), but analysts do not expect the company to be profitable for the year. In Q1 2026 the company reported a loss per share of $-1.06 on revenue of $115.24 million and cited operational progress, including an increase in power capacity of about 1.2 GW, featuring a new 430 MW site in Hunt County, Texas. BTIG raised its price target to $33 and reiterated a "Buy" rating. » More on de.investing.com

At the 2026 annual general meeting, shareholders elected five members to Core Scientific’s board of directors for a term running to 2027 and approved, in a non-binding vote, the executive compensation. Shareholders ratified KPMG LLP as the independent auditor for the fiscal year ending December 31, 2026. Core Scientific reported a loss per share of $1.06 for Q1 2026 on revenue of $115.24 million and continues to expand its colocation infrastructure, including about 1.2 GW of additional power capacity and a new 430 MW site in Hunt County, Texas. BTIG raised its price target to $33 and maintained its 'Buy' rating following the capacity expansion. » More on de.investing.com